Chemical modification and co-administration approaches Modifying the amino acid backbone or chemically conjugating the peptide can increase stability
Tirzepatide (brand name Mounjaro) is a dual GLP-1 and GIP receptor agonist that has demonstrated significant weight loss results in clinical trials, but its potency depends entirely on proper storage
STEP UP Trial This newer study used a higher dose (7.2 mg)
Quality manufacturers typically provide: Lot numbers Manufacturing records Sterility testing Certificate of Analysis Comparison Table Choosing a Quality Supplier Look for suppliers offering: COA documentation Lot traceability Secure packaging Professional labeling Laboratory-grade manufacturing Conclusion Although both products are sterile, bacteriostatic water includes a preservative that differentiates it from standard sterile water.
The increase in dosage follows a stepwise approach, going up only after assessing your response and side effects from the current dose
Newer GLP-1 options Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, is in late-stage clinical trials and showing even greater weight loss potential than current options
